Lele Zhou - Publications

Corrigendum to "Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway" [J. Ethnopharmacol. 329 118145].

Journal: Journal of ethnopharmacology

Published: April 10, 2025

Corrigendum to "Acori Tatarinowii Rhizoma regulates OCT3/OATP2 and P-gp/MRP1 to "guide medicines upwards" in Kai-Xin-San to treat Alzheimer's disease [J. Ethnopharmacol. 343 (2025) 119484].

Journal: Journal of ethnopharmacology

Published: March 13, 2025

Acori Tatarinowii Rhizoma regulates OCT3/OATP2 and P-gp/MRP1 to "guide medicines upwards" in Kai-Xin-San to treat Alzheimer's disease.

Journal: Journal of ethnopharmacology

Published: December 26, 2024

Recent Insights on the Role of Nuclear Receptors in Alzheimer's Disease: Mechanisms and Therapeutic Application.

Journal: International journal of molecular sciences

Published: December 05, 2024

Evaluation of 3-O-β-D-galactosylated resveratrol-loaded polydopamine nanoparticles for hepatocellular carcinoma treatment.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 10, 2024

Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway.

Journal: Journal of ethnopharmacology

Published: January 31, 2024

Research on the quality markers of antioxidant activity of Kai-Xin-San based on the spectrum-effect relationship.

Journal: Frontiers in pharmacology

Published: August 03, 2023

Preparation of paeoniflorin-glycyrrhizic acid complex transethosome gel and its preventive and therapeutic effects on melasma.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: July 25, 2023